Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb 22;8(1):102.
doi: 10.1186/1556-276X-8-102.

Liposome: classification, preparation, and applications

Abolfazl Akbarzadeh  1 , Rogaie Rezaei-Sadabady, Soodabeh Davaran, Sang Woo Joo, Nosratollah Zarghami, Younes Hanifehpour, Mohammad Samiei, Mohammad Kouhi, Kazem Nejati-Koshki
Affiliations

Liposome: classification, preparation, and applications

Abolfazl Akbarzadeh et al. Nanoscale Res Lett. .

Abstract

Liposomes, sphere-shaped vesicles consisting of one or more phospholipid bilayers, were first described in the mid-60s. Today, they are a very useful reproduction, reagent, and tool in various scientific disciplines, including mathematics and theoretical physics, biophysics, chemistry, colloid science, biochemistry, and biology. Since then, liposomes have made their way to the market. Among several talented new drug delivery systems, liposomes characterize an advanced technology to deliver active molecules to the site of action, and at present, several formulations are in clinical use. Research on liposome technology has progressed from conventional vesicles to 'second-generation liposomes', in which long-circulating liposomes are obtained by modulating the lipid composition, size, and charge of the vesicle. Liposomes with modified surfaces have also been developed using several molecules, such as glycolipids or sialic acid. This paper summarizes exclusively scalable techniques and focuses on strengths, respectively, limitations in respect to industrial applicability and regulatory requirements concerning liposomal drug formulations based on FDA and EMEA documents.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. DDT. 2003;8:24. - PubMed
    1. Gabizon A, Goren D, Cohen R, Barenholz Y. Development of liposomal anthracyclines: from basics to clinical applications. J Control Release. 1998;53:275–279. doi: 10.1016/S0168-3659(97)00261-7. - DOI - PubMed
    1. Allen TM. Liposomes. Opportunities in drug delivery. Drugs. 1997;54(Suppl 4):8–14. - PubMed
    1. Chrai SS, Murari R, Imran A. Liposomes: a review. Bio Pharm. 2001;14(11):10–14.
    1. Andreas W, Karola VU. Liposome technology for industrial purposes. J Drug Deliv. 2011;2011:9. - PMC - PubMed